Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,766.40
(
-1.52%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
107.29
(
6.60%
)
Bitcoin
71,265.40
(
-3.62%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: masterlongevity post# 3920

Sunday, 06/24/2007 6:08:33 PM

Sunday, June 24, 2007 6:08:33 PM

Post# of 19309
>how will physicians make money off follow-on biologics. Will they get paid at similar rate to inject FOBs or will this be a hurdle for prescribing?<

Good question. As NVS’ Omnitrope is now approved, NVS’ IR department ought to be able to give us an answer.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today